Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Dehydroglyasperin D exhibits anticancer, anti-inflammatory, anti-obesity, Antioxidant and anti-aldose Reductase effects, it inhibits the proliferation of HT-29 human colorectal cancer cells through direct interaction with phosphatidylinositol 3-kinase; it also mediates suppression of both COX-2 expression and the MLK3 signalling pathway through direct binding and inhibition of MLK3. Dehydroglyasperin D shows strong ferric reducing activities and effectively scavenged DPPH, ABTS(+), and singlet oxygen radicals.
Description | Dehydroglyasperin D exhibits anticancer, anti-inflammatory, anti-obesity, antioxidant and anti-aldose reductase effects, it inhibits the proliferation of HT-29 human colorectal cancer cells through direct interaction with phosphatidylinositol 3-kinase; it also mediates suppression of both COX-2 expression and the MLK3 signalling pathway through direct binding and inhibition of MLK3. Dehydroglyasperin D shows strong ferric reducing activities and effectively scavenged DPPH, ABTS(+), and singlet oxygen radicals. |
Molecular Weight | 368.42 |
Formula | C22H24O5 |
CAS No. | 517885-72-2 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dehydroglyasperin D 517885-72-2 Cell Cycle/Checkpoint Cytoskeletal Signaling DNA Damage/DNA Repair GPCR/G Protein Immunology/Inflammation MAPK Neuroscience PI3K/Akt/mTOR signaling Stem Cells ROS PI3K DNA/RNA Synthesis COX Akt Prostaglandin Receptor JNK GSK-3 p38 MAPK Inhibitor inhibitor inhibit